Principal Investigator

New York Oncology Hematology•Albany, NY
•Hybrid

About The Position

The Principal Investigator (PI) role is a critical leadership position within a practice at the forefront of cutting-edge cancer care and advanced treatments. This role offers opportunities for professional growth, continuing education, and the chance to work alongside a collaborative and compassionate team of experts. The PI will contribute to groundbreaking clinical trials that shape the future of oncology care and discover their career potential with a practice dedicated to excellence and innovation. The position is structured in phases aligned to site readiness and go-live, with varying time commitments. The PI will support site readiness activities, complete necessary documentation, and provide clinical oversight during the launch and early operational periods. A structured handoff to a full-time Physician Investigator Site Leader is expected, with potential for ongoing involvement.

Requirements

  • Physician investigator activity at the site until a full-time Physician Investigator Site Leader assumes that responsibility.
  • Pre-Launch (Months 2–3 before go-live): a few hours per week, focused on protocol and study selection input, credentialing, regulatory and IRB set-up, and early staff engagement.
  • Final Month Before Go-Live: time commitment increases to approximately 16 hours per week.
  • Includes an on-site visit of up to one week at an established NYOH/START clinic to become familiar with START systems, workflows, and documentation standards.
  • Go-Live and Early Operations: continues at approximately 16 hours per week as the site's Principal Investigator, providing patient-facing and protocol oversight through the early operational period.
  • Transition: upon hire of a full-time Physician Investigator Site Leader, the Launch PI typically transitions out of the interim PI role.
  • It is not unusual for the Launch PI to remain engaged with the Phase 1 unit in an ongoing capacity of approximately 1–2 days per week thereafter.

Nice To Haves

  • Be part of a practice at the forefront of cutting-edge cancer care and advanced treatments
  • Access opportunities for professional growth and continuing education.
  • Work alongside a collaborative and compassionate team of experts dedicated to making a difference.
  • Enjoy the convenience of multiple locations throughout the Capital Region.
  • Contribute to groundbreaking clinical trials that shape the future of oncology care.
  • Discover your career potential with a practice dedicated to excellence and innovation.

Responsibilities

  • Support site readiness activities in partnership with Clinical Operations and Technology leadership, including protocol selection input, feasibility review, and study start-up sequencing.
  • Complete credentialing, privileging, and required regulatory documentation ahead of go-live.
  • Participate in site build-out planning, including capacity, staffing, and workflow design specific to Phase 1 requirements.
  • Complete on-site training at a reference NYOH/START clinic to gain familiarity with START systems, standard operating procedures, and documentation practices.
  • Serve as the site's Principal Investigator for enrolled protocols during the interim period, providing new patient consults, consent visits, safety follow-ups, and infusion oversight as required.
  • Ensure timely completion of protocol-required investigator activities, including data entry and safety reporting.
  • Serve as the point of clinical escalation for physician-dependent decisions at the site until a full-time Physician Investigator Site Leader is in place.
  • Coordinate with Nursing, Clinical Research Coordinators, Regulatory, and Marketing to support clinic operations and communication during the ramp-up period.
  • Provide input to site leadership on study selection and portfolio fit as the unit builds its early caseload.
  • Support a structured handoff of patients, protocols, and site knowledge to the incoming full-time Physician Investigator Site Leader.
  • Where mutually agreed, continue in an ongoing capacity within the Phase 1 unit (approximately 1–2 days per week) following the transition to full-time leadership.
  • Provide mentorship to incoming and junior investigators as needed to support continuity of clinical research capability at the site.

Benefits

  • opportunities for professional growth
  • continuing education
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service